Oxidation of methionine 63 and 83 regulates the effect of S100A9 on the migration of neutrophils in vitro

被引:57
作者
Sroussi, Herve Y.
Berline, Jennifer
Palefsky, Joel M.
机构
[1] UIC Coll Dent, Dept Oral Med & Diagnost Sci, Chicago, IL 60612 USA
[2] Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA USA
关键词
calprotectin; chemotaxis; fugetaxis;
D O I
10.1189/jlb.0706433
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The calcium-binding proteins S100A8 and S100A9 and their heterocomplex calprotectin are abundant cytosolic constituents in human neutrophils, constitutively expressed by mucosal epithelium. and in association with inflammation by epidermal keratinocytes. S100A8 and S100A9 are pleiotropic proteins, which partake in the regulation of leukocyte migration. This study was designed to investigate the effect of S100A9 on neutrophil migration and to explore the mechanisms that regulate this effect. Based on previous results with S100A8, we hypothesized that S100A9 repels neutrophils and that oxidation of S100A9 regulates this function. Using standard Transwell chemotaxis assays and site-directed mutagenesis, we show that S100A9 exerts a chemo-repulsive (fugetactic) effect on peripheral neutrophils, an effect abolished by oxidation of S100A9. After substitution of methionine 63 and 83 for alanine, S100A9 maintained its fugetaxis activity, even in inhibitory, oxidative conditions. Together, the data suggest that S100A9 serves as a molecular switch for oxidative control of inflammation regulated by the oxidation of species-conserved methionine residues. In healthy mucosal tissue, expression of S100A9 by the epithelium may serve to inhibit leukocyte recruitment. However, conditions of oxidative stress, including infection and overgrowth of opportunistic pathogens, may abrogate this activity by neutralizing S100A9 as a result of its oxidative alteration.
引用
收藏
页码:818 / 824
页数:7
相关论文
共 44 条
[1]   THE LEUKOCYTE L1-PROTEIN - IDENTITY WITH THE CYSTIC-FIBROSIS ANTIGEN AND THE CALCIUM-BINDING MRP-8 AND MRP-14 MACROPHAGE COMPONENTS [J].
ANDERSSON, KB ;
SLETTEN, K ;
BERNTZEN, HB ;
DALE, I ;
BRANDTZAEG, P ;
JELLUM, E ;
FAGERHOL, MK .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1988, 28 (02) :241-245
[2]   Redox modulation of cellular signaling and metabolism through reversible oxidation of methionine sensors in calcium regulatory proteins [J].
Bigelow, DJ ;
Squier, TC .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2005, 1703 (02) :121-134
[3]  
BROT N, 1991, BIOFACTORS, V3, P91
[4]   Responses of leukocytes to chemokines in whole blood and their antagonism by novel CC-chemokine receptor 3 antagonists [J].
Bryan, SA ;
Jose, PJ ;
Topping, JR ;
Wilhelm, R ;
Soderberg, C ;
Kertesz, D ;
Barnes, PJ ;
Williams, TJ ;
Hansel, TT ;
Sabroe, I .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 165 (12) :1602-1609
[5]  
Dalpiaz A., 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P33, DOI 10.2174/1568008033340333
[6]   The S100A8/A9 protein as a partner for the cytosolic factors of NADPH oxidase activation in neutrophils [J].
Doussiere, J ;
Bouzidi, F ;
Vignais, PV .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2002, 269 (13) :3246-3255
[7]  
EDGEWORTH J, 1991, J BIOL CHEM, V266, P7706
[8]   Multistep navigation and the combinatorial control of leukocyte chemotaxis [J].
Foxman, EF ;
Campbell, JJ ;
Butcher, EC .
JOURNAL OF CELL BIOLOGY, 1997, 139 (05) :1349-1360
[9]   SEQUENCE IDENTITY [J].
FREEMONT, P ;
HOGG, N ;
EDGEWORTH, J .
NATURE, 1989, 339 (6225) :516-516
[10]   Expression of MRP8 and MRP14 by macrophages is a marker for severe forms of glomerulonephritis [J].
Frosch, M ;
Vogl, T ;
Waldherr, R ;
Sorg, C ;
Sunderkötter, C ;
Roth, J .
JOURNAL OF LEUKOCYTE BIOLOGY, 2004, 75 (02) :198-206